Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -317.20% is 64% below its 5-year average of -193.07%, near the low end of its 5-year range (-439.12%–-3.57%).
As of the fiscal period ended Tuesday, June 30, 2026. 37.34% below its 12-month average of -230.97%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -317.20%.
RETURN ON EQUITY (ROE)
-317.20%
RETURN ON EQUITY (ROE) AVG TTM
-230.97%
RETURN ON EQUITY (ROE) AVG 3Y
-230.97%
RETURN ON EQUITY (ROE) AVG 5Y
-193.07%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-37.34%
CURRENT VS 3Y AVG
-37.34%
CURRENT VS 5Y AVG
-64.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.30%
median of 656 covered companies
CURRENT VS SECTOR MEDIAN
-687.00%
vs the sector median at left
SeaStar Medical Holding Corporation
Market Cap
$9.22M
Return on Equity (ROE)
-317.20%
TTM Avg
-230.97%
3Y Avg
-230.97%
5Y Avg
-193.07%
Market Cap
$9.22M
Return on Equity (ROE)
-7.36%
TTM Avg
-85.10%
3Y Avg
-73.72%
5Y Avg
-96.61%
Market Cap
$9.14M
Return on Equity (ROE)
-2248.48%
TTM Avg
-970.82%
3Y Avg
-532.13%
5Y Avg
-347.08%
Market Cap
$9.65M
Return on Equity (ROE)
-211.76%
TTM Avg
-295.58%
3Y Avg
-182.53%
5Y Avg
-207.81%
Market Cap
$9.72M
Return on Equity (ROE)
-440.15%
TTM Avg
-145.56%
3Y Avg
-96.97%
5Y Avg
-42.16%
Market Cap
$9.75M
Return on Equity (ROE)
-189.76%
TTM Avg
-774.75%
3Y Avg
-460.85%
5Y Avg
-442.56%
Market Cap
$9.92M
Return on Equity (ROE)
-252.37%
TTM Avg
-195.20%
3Y Avg
-116.68%
5Y Avg
-90.09%
Market Cap
$10.04M
Return on Equity (ROE)
N/A
TTM Avg
18596.99%
3Y Avg
9182.42%
5Y Avg
7349.85%
Market Cap
$8.42M
Return on Equity (ROE)
-34.67%
TTM Avg
10.89%
3Y Avg
102.13%
5Y Avg
71.00%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SeaStar Medical Holding Corporation (ICU) | $9.22M | -317.20% | -230.97% | -230.97% | -193.07% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.22M | -7.36% | -85.10% | -73.72% | -96.61% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.14M | -2248.48% | -970.82% | -532.13% | -347.08% |
| MetaVia Inc. (MTVA)vs › | $9.65M | -211.76% | -295.58% | -182.53% | -207.81% |
| Ainos, Inc. (AIMD)vs › | $9.72M | -440.15% | -145.56% | -96.97% | -42.16% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.75M | -189.76% | -774.75% | -460.85% | -442.56% |
| Lifeward Ltd. (LFWD)vs › | $9.92M | -252.37% | -195.20% | -116.68% | -90.09% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.04M | N/A | 18596.99% | 9182.42% | 7349.85% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.42M | -34.67% | 10.89% | 102.13% | 71.00% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.36M | -57.34% | -65.47% | -124.96% | 28.05% |
ROE
-317.2%
ROA
-157.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -317.20% |
| 2026-03-31 | -162.67% |
| 2025-12-31 | -116.65% |
| 2025-09-30 | -119.20% |
| 2025-06-30 | -439.12% |
| 2021-09-30 | -3.57% |
